相关实验视频

Jiwei Zhang1, Fen Ma1, Zhe Li2

  • 1Shanghai Key Laboratory of Compound Chinese Medicines The MOE Key Laboratory for Standardization of Chinese Medicines Institute of Chinese Materia Medica Shanghai University of Traditional Chinese Medicine Shanghai China.

MedComm
|April 25, 2024
PubMed
概括

核因子卡帕B亚单元2 (NFKB2) 通过升调PD-L1.1,促进结直肠癌 (CRC) 的生长和免疫逃生. 准NFKB2可能会提高CRC患者的免疫疗法的有效性.

相关概念视频